Tonje Amb Aksnes
Position: MD, PhD
Phone: +4702900
Email:
Department of Cardiology, Akershus University Hospital, Oslo, Norway
 

Author network for Tonje Amb Aksnes by COREMINE medical


Publications 2016

Aksnes TA, Kjeldsen SE, Rostrup M, Holzhauer B, Hua TA, Julius S (2016)
Predictors of cardiac morbidity in diabetic, new-onset diabetic and non-diabetic high-risk hypertensive patients: The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial
Blood Press, 25 (4), 235-40
PubMed 26808585

Kjeldsen SE, Aksnes TA, Wachtell K, Okin PM (2016)
Arterial Stiffness Predicts Incident Atrial Fibrillation in the Framingham Heart Study: A Mechanistic Contribution in People With High Blood Pressure or History of Hypertension
Hypertension, 68 (3), 555-7
PubMed 27456524

Publications 2015

Skårn SN, Eggesbø HB, Flaa A, Kjeldsen SE, Rostrup M, Brunborg C, Reims HM, Aksnes TA (2015)
Predictors of abdominal adipose tissue compartments: 18-year follow-up of young men with and without family history of diabetes
Eur J Intern Med, 29, 26-31
PubMed 26712453

Skårn SN, Flaa A, Kjeldsen SE, Rostrup M, Brunborg C, Reims HM, Fossum E, Høieggen A, Aksnes TA (2015)
Family history of hypertension and serum triglycerides predict future insulin sensitivity: a 17-year follow-up study of young men
J Hypertens, 33 (9), 1845-51; discussion 1852
PubMed 26103130

Skårn SN, Flaa A, Kjeldsen SE, Rostrup M, Brunborg C, Reims HM, Fossum E, Høieggen A, Aksnes TA (2015)
High screening blood pressure at young age predicts future masked hypertension: A 17 year follow-up study
Blood Press, 24 (3), 131-8
PubMed 25901999

Publications 2014

Gerdts E, Aksnes TA, Hultström M, Kjeldsen SE, Os I (2014)
Ingrid Toft (June 2, 1959-April 26, 2014)
Blood Press, 23 (4), 255
PubMed 25014276

Kjeldsen SE, Aksnes TA, Ruilope LM (2014)
Clinical implications of the 2013 ESH/ESC hypertension guidelines: targets, choice of therapy, and blood pressure monitoring
Drugs R D, 14 (2), 31-43
PubMed 24842751

Publications 2013

Kjeldsen SE, Schultz M, Vinkenes K, Aksnes TA, Høieggen A (2013)
[Blood Pressure Treatment--towards consensus on many things]
Tidsskr Nor Laegeforen, 133 (21), 2226
PubMed 24226313

Schultz M, Aksnes TA, Høieggen A, Kjeldsen SE (2013)
[Choice of drug in hypertension]
Tidsskr Nor Laegeforen, 133 (17), 1802-3
PubMed 24042290

Publications 2012

Aksnes TA, Skårn SN, Kjeldsen SE (2012)
Treatment of hypertension in diabetes: what is the best therapeutic option?
Expert Rev Cardiovasc Ther, 10 (6), 727-34
PubMed 22894629

Publications 2011

Hultstrom M, Aksnes TA, Gerdts E, Kjeldsen SE, Toft I (2011)
Bjarne Magnus Iversen (30 March 1942-5 August 2011) OBITUARY
Blood Pressure, 20 (5), 317

Publications 2010

Aksnes TA, Kjeldsen SE (2010)
A link between hypertension and atrial fibrillation: methods of treatment and prevention
Curr Vasc Pharmacol, 8 (6), 769-74
PubMed 20626338

Publications 2009

Aksnes TA, Kjeldsen SE, Schmieder RE (2009)
Hypertension and atrial fi brillation with emphasis on prevention
Blood Press, 18 (3), 94-8
PubMed 20499443

Publications 2008

Aksnes TA, Flaa A, Sevre K, Mundal HH, Rostrup M, Kjeldsen SE (2008)
Effects on plasma noradrenaline may explain some of the improved insulin sensitivity seen by AT-1 receptor blockade
Blood Press, 17 (3), 156-63
PubMed 18608197

Aksnes TA, Flaa A, Strand A, Kjeldsen SE (2008)
Prevention of atrial fibrillation in hypertension
Curr Hypertens Rep, 10 (3), 175-81
PubMed 18765086

Aksnes TA, Kjeldsen SE, Rostrup M, Störset O, Hua TA, Julius S (2008)
Predictors of new-onset diabetes mellitus in hypertensive patients: the VALUE trial
J Hum Hypertens, 22 (8), 520-7
PubMed 18509347

Aksnes TA, Schmieder RE, Kjeldsen SE, Ghani S, Hua TA, Julius S (2008)
Impact of new-onset diabetes mellitus on development of atrial fibrillation and heart failure in high-risk hypertension (from the VALUE Trial)
Am J Cardiol, 101 (5), 634-8
PubMed 18308012

Flaa A, Aksnes TA, Kjeldsen SE, Eide I, Rostrup M (2008)
Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study
Metabolism, 57 (10), 1422-7
PubMed 18803948

Publications 2007

Aksnes TA, Flaa A, Strand A, Kjeldsen SE (2007)
Prevention of new-onset atrial fibrillation and its predictors with angiotensin II-receptor blockers in the treatment of hypertension and heart failure
J Hypertens, 25 (1), 15-23
PubMed 17143167

Aksnes TA, Kjeldsen SE, Rostrup M, Omvik P, Hua TA, Julius S (2007)
Impact of new-onset diabetes mellitus on cardiac outcomes in the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial population
Hypertension, 50 (3), 467-73
PubMed 17679652

Aksnes TA, Seljeflot I, Torjesen PA, Höieggen A, Moan A, Kjeldsen SE (2007)
Improved insulin sensitivity by the angiotensin II-receptor blocker losartan is not explained by adipokines, inflammatory markers, or whole blood viscosity
Metabolism, 56 (11), 1470-7
PubMed 17950096

Flaa A, Aksnes TA, Strand A, Kjeldsen SE (2007)
Complications of hypertension and the role of angiotensin receptor blockers in hypertension trials
Expert Rev Cardiovasc Ther, 5 (3), 451-61
PubMed 17489670

Publications 2006

Aksnes TA, Kjeldsen SE, Mancia G (2006)
The effect of antihypertensive agents on new-onset diabetes mellitus: time to amend the guidelines?
Am J Cardiovasc Drugs, 6 (3), 139-47
PubMed 16780387

Aksnes TA, Reims HM, Guptha S, Moan A, Os I, Kjeldsen SE (2006)
Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors
J Hum Hypertens, 20 (11), 860-6
PubMed 16988754

Publications 2005

Aksnes TA, Reims HM, Kjeldsen SE, Mancia G (2005)
Antihypertensive treatment and new-onset diabetes mellitus
Curr Hypertens Rep, 7 (4), 298-303
PubMed 16061050

Publications 2004

Aksnes TA, Jacobsen D (2004)
[Smuggling of illegal drugs by body suffers]
Tidsskr Nor Laegeforen, 124 (13-14), 1772-3
PubMed 15229664

Publications 2000

Aksnes TA, Nodenes K, Gjesdal K (2000)
[Use of tilt test in the investigation of syncope]
Tidsskr Nor Laegeforen, 120 (7), 803-6
PubMed 10806903